Literature DB >> 12043888

Fcgamma and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients.

C M Marzocchi-Machado1, C M O S Alves, A E C S Azzolini, A C M Polizello, I F Carvalho, Y M Lucisano-Valim.   

Abstract

We have investigated the individual role of FcgammaR and CR, as well as their cooperation, in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus (SLE) patients. Neutrophils were stimulated with the immune complexes (IC)-IgG or -F(ab')2, opsonized or not with normal or SLE human serum. The oxidative burst was decreased in neutrophils of active SLE patients compared to healthy controls when this response was mediated by FcgammaR and/or CR, while the degranulation was unaffected. The SLE hypocomplementemia did not affect the oxidative burst mediated only by CR. FcgammaRII and CR1 expression on neutrophils of active SLE patients was reduced, while the expression of FcgammaRIII and CR3 was unaffected. These results suggest that the different FcgammaR and CR may be involved or cooperate in different ways in the mediation of the oxidative burst and the degranulation. Moreover, the decreased oxidative burst of neutrophils of active SLE patients may not depend only on SLE hypocomplementemia for IC opsonization. These observations are directed at the understanding of how each of these immune system components (FcgammaR, CR and complement) influences the precise biological neutrophil responses both in physiological and pathological conditions. Since the Brazilian population comprises many races, these results are important because they are directed at a specific population of SLE patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12043888     DOI: 10.1191/0961203302lu172oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  12 in total

Review 1.  Neutrophils in the pathogenesis and manifestations of SLE.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

2.  IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.

Authors:  Dan Li; Bharati Matta; Su Song; Victoria Nelson; Kirsten Diggins; Kim R Simpfendorfer; Peter K Gregersen; Peter Linsley; Betsy J Barnes
Journal:  JCI Insight       Date:  2020-01-30

Review 3.  The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetes.

Authors:  Xiaoquan Rao; Jixin Zhong; Qinghua Sun
Journal:  Life Sci       Date:  2014-09-28       Impact factor: 5.037

Review 4.  Luminol-based chemiluminescent signals: clinical and non-clinical application and future uses.

Authors:  Parvez Khan; Danish Idrees; Michael A Moxley; John A Corbett; Faizan Ahmad; Guido von Figura; William S Sly; Abdul Waheed; Md Imtaiyaz Hassan
Journal:  Appl Biochem Biotechnol       Date:  2014-04-22       Impact factor: 2.926

5.  Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate.

Authors:  Larissa F Marchi; Adriana B Paoliello-Paschoalato; Renê D R Oliveira; Ana Elisa C S Azzolini; Luciana M Kabeya; Eduardo A Donadi; Yara Maria Lucisano-Valim
Journal:  Rheumatol Int       Date:  2018-02-20       Impact factor: 2.631

6.  4-methylcoumarin derivatives inhibit human neutrophil oxidative metabolism and elastase activity.

Authors:  Luciana M Kabeya; Carolina N Fuzissaki; Micássio F Andrade; Ana Elisa C S Azzolini; Silvia H Taleb-Contini; Roberta B Vermelho; João Luis C Lopes; Yara Maria Lucisano-Valim
Journal:  J Med Food       Date:  2013-08-01       Impact factor: 2.786

7.  Superoxide release in juvenile systemic lupus erythematosus.

Authors:  Roberto Marini; Antonio Condino-Neto; Simone Appenzeller; André M Morcillo; Lilian T L Costallat
Journal:  Rheumatol Int       Date:  2011-04-03       Impact factor: 2.631

8.  A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.

Authors:  Michael F Denny; Srilakshmi Yalavarthi; Wenpu Zhao; Seth G Thacker; Marc Anderson; Ashley R Sandy; W Joseph McCune; Mariana J Kaplan
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

9.  Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus.

Authors:  Celene M O S Alves; Cleni M Marzocchi-Machado; Paulo Louzada-Junior; Ana Elisa C S Azzolini; Ana Cristina M Polizello; Ivan F de Carvalho; Yara M Lucisano-Valim
Journal:  Clin Rheumatol       Date:  2007-10-23       Impact factor: 2.980

Review 10.  Fcγ and Complement Receptors and Complement Proteins in Neutrophil Activation in Rheumatoid Arthritis: Contribution to Pathogenesis and Progression and Modulation by Natural Products.

Authors:  Adriana Balbina Paoliello-Paschoalato; Larissa Fávaro Marchi; Micássio Fernandes de Andrade; Luciana Mariko Kabeya; Eduardo Antônio Donadi; Yara Maria Lucisano-Valim
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.